Dr. Karasic on Phase II Trial of Nivolumab and Ipilimumab for Mucinous Colorectal & Appendiceal Tumors

Thomas Karasic, MD, University of Pennsylvania, speaks on "Phase II Trial of Nivolumab and Ipilimumab for Mucinous Colorectal & Appendiceal Tumors" at the Drexel PMP/Appendiceal Cancer Seminar